Objectives: To study effect of erythropoietin (EPO) on some aspects of carbohydrate and lipid metabolism in obese and diabetic rats. Material and methods. This study was carried on (50) albino female rats; divided into 5 groups, each consisted of 10 rats: Control, obese, diabetic, erythropoietin treated obese group (after induction of obesity it was injected by erythropoietin 600u/kg I.P. once daily every other day for 5 weeks) and erythropoietin treated diabetic group (after induction of diabetes it was treated as previous group). At the end of experimental period serum samples were collected for estimation of: fasting serum glucose, serum insulin, insulin resistance (HOMA IR), insulin sensitivity (HOMA S%), serum LDL, serum HDL, serum triglyceride (TG), serum cholesterol, glycosylated Hb% and measurement of body mass Index (BMI) Results: Erythropoietin treated obese group showed significant decrease in fasting glucose, insulin, HOMA IR, serum LDL, TG, cholesterol and BMI. While, serum HDL and HOMA S% were significantly increased when these results were compared to obese group.
INTRODUCTION
In the last few decades, the prevalence of obesity and diabetes has been increasing rapidly (1) . There is strong association between obesity , cardiovascular disease, type 2diabetes and other chronic diseases, this trend suggests a substantial increase in obesity -related morbidity and mortality for the future (2) ,as regarding diabetes mellitus its effect include long term damage, 
MATERIALS AND METHODS

Animals
The present work was carried on 50 female albino rats ranging in weight between 160-180g, 12-16 weeks old. The rats were housed in isolated animal cages, in a standard animal laboratory room and had free access to water and food all over the period of the work, and kept at room temperature.
The animals were divided into five groups (10 rats in each group): 
Statistical analysis:
The data were expressed as the mean ± standard deviation. Data from our study were analyzed using the unpaired student's t-test to assess significant difference between two groups. Pvalues <0.05 were considered statistically significant. All the analyses were performed using Graph Pad Instat, 32 bit for win 95/NT (Version 3.05). Results of the present work revealed significant decrease in serum insulin and HOMA-IR when EPO is administrated to obese rats which could be due to reducing the transcription factor enhancing binding protein alpha (CEBP/α). This transcription factor play role in insulin sensitivity as it is required during adipogenesis for development of insulin-stimulated glucose uptake (27). EPO 
RESULTS
Our
